Table of Contents Author Guidelines Submit a Manuscript
Research Letters in Biochemistry
Volume 2008, Article ID 639829, 4 pages
http://dx.doi.org/10.1155/2008/639829
Research Letter

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots

Henderson Research Centre, McMaster University, 711 Concession Street, Hamilton, L8V 1C3 Ontario, Canada

Received 15 February 2008; Accepted 5 April 2008

Academic Editor: Robert J. Linhardt

Copyright © 2008 Lesley J. Smith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Meddahi, L. Bara, H. Fessi, and M. M. Samama, “Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin,” Blood Coagulation and Fibrinolysis, vol. 11, no. 1, pp. 51–59, 2000. View at Google Scholar
  2. R. M. Maaroufi, M. Jozefowicz, J. Tapon-Bretaudière, and A.-M. Fischer, “Mechanism of thrombin inhibition by antithrombin and heparin cofactor II in the presence of heparin,” Biomaterials, vol. 18, no. 3, pp. 203–211, 1997. View at Publisher · View at Google Scholar
  3. D. L. Becker, J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz, “Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II,” Journal of Biological Chemistry, vol. 274, no. 10, pp. 6226–6233, 1999. View at Publisher · View at Google Scholar
  4. H. van Aken, C. Bode, H. Darius et al., “Anticoagulation: the present and future,” Clinical and Applied Thrombosis/Hemostasis, vol. 7, no. 3, pp. 195–204, 2001. View at Publisher · View at Google Scholar
  5. A. Chan, L. Berry, H. O'Brodovich et al., “Covalent antithrombin-heparin complexes with high anticoagulant activity: intravenous, subcutaneous, and intratracheal administration,” Journal of Biological Chemistry, vol. 272, no. 35, pp. 22111–22117, 1997. View at Publisher · View at Google Scholar
  6. L. R. Berry, D. L. Becker, and A. K. C. Chan, “Inhibition of fibrin-bound thrombin by a covalent antithrombin-heparin complex,” Journal of Biochemistry, vol. 132, no. 2, pp. 167–176, 2002. View at Google Scholar
  7. W. Li, D. J. D. Johnson, C. T. Esmon, and J. A. Huntington, “Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin,” Nature Structural & Molecular Biology, vol. 11, no. 9, pp. 857–862, 2004. View at Publisher · View at Google Scholar
  8. A. K. C. Chan, L. Berry, P. Klement et al., “A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits,” Blood Coagulation and Fibrinolysis, vol. 9, no. 7, pp. 587–595, 1998. View at Google Scholar